Bladder Neoplams- MIBC Flashcards
Bladder cancer hematogenous metastasis
Both lymphatic and hematogenous metastasis occur. About 33% of pts who die of metastatic bladder cancer have negative pelvic nodes. Common hematogenous locations- liver (38%), lung (36%), bone, adrenal, intenstine.
Bladder cancer lymphatic metastasis
Level I nodes: internal and external iliac and obturator
Level II nodes: common iliac and sacral
Level III nodes: paraortic, paracaval, and interaortocaval
note: in 7% of cases level II is involved even though level I is not; III is never involved without lower levels
Clinical staging factors
Takes into acct. pathologic staging of TURBT, bimanual exam, and imaging. Do CT A/P w/ and w/o and CT chest (or at least CXR).
PET scan for bladder cancer
PET scan for bladder cancer- sens. 82%, spec. 89%
Radical cystectomy- male
Radical cystectomy in the male patient includes removal of the bladder, the perivesical fat, the prostate, seminal vesicles and pelvic lymph nodes. Urethrectomy is rarely performed at time of RCP; do interval urethrectomy if final path shows +urethral margin.
Radical cystectomy- female
removal of the bladder, the perivesical fat, the pelvic lymph nodes, the uterus, cervix, fallopian tubes, ovaries and the anterior vagina- consider vaginal sparing surgery for pts with low stage disease
Boundaries of lymphadenectomy for RCP
Superior- common iliac vessels
Inferior- inguinal ligament
Medial- bladder
Lateral- pelvic sidewall and genitofemoral nerve
MIBC survival
Overall 5yr survival of 36-48%
for T3, T4, or node positive drops to 30%
Neoadjuvant chemotherapy for MIBC
5-7% improvement in survival
MVAC followed by cystectomy had median survival of 77mos vs. 46mos for cystectomy alone.
GC is sometimes used in place to avoid morbidity.
Adjuvant chemotherapy for MIBC
Adjuvant chemo (after cystectomy but before recurrence) has not been shown to be beneficial
Complications following cystectomy
64% have at least one perioperative complication within 90d, 13% have grade III or higher complication
Ileal conduit complications
upper tract deterioration, urinary tract infections, stomal or parastomal hernia, and peri-stoma skin irritation
Orthotopic diversion contraindication
Positive urethral margin, extensive extravesical disease, pubic bone involvement, plans for radiation, urethral strictures, bowel disease, renal or hepatic insufficiency
Incontinence after orthotopic diversion
10-15% daytime incontinence
20-30% nighttime incontinence
Partial cystectomy
Consider for isolated tumor at dome or tumor in diverticulum